Please assess the completion status of the following clinical trial:

Trial Title: Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects between 3 to 6 months of age at the enrollment.~* Available for the entire study period and whose parent/legal guardian can be reached by telephone.~* Healthy infant as determined by medical history, physical examination, and judgement of the investigator.~Exclusion Criteria:~* Previous vaccination with licensed or investigational pneumococcal, diphtheria, tetanus, or pertussis vaccines.~* A previous anaphylactic reaction to any vaccine or vaccine-related component.~* Bleeding diathesis or condition associated with prolonged bleeding time that would contraindicate any type of injection.~* History of culture-proven invasive disease caused by S pneumoniae (eg, meningitis, bacteremia, osteomyelitis, arthritis).~* Infant who is a direct descendant (child, grandchild) of the study site personnel.

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Experimental
- 2 (Type: ACTIVE_COMPARATOR): Active comparator
- 3 (Type: ACTIVE_COMPARATOR): Active comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).